Supriya Lifescience receives USFDA EIR with VAI classification for Maharashtra API facility
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
Subscribe To Our Newsletter & Stay Updated